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motoneurons and restores axon elongation. This effect is 
mediated by interaction of neurofilament with the stath-
min complex. Accumulating neurofilaments associate with 
stathmin in axons of pmn mutant motoneurons. Depletion 
of neurofilament by Nefl knockout increases Stat3–stathmin 
interaction and stabilizes the microtubules in pmn mutant 
motoneurons. Consequently, counteracting enhanced neu-
rofilament expression improves axonal maintenance and 
prolongs survival of pmn mutant mice. We propose that this 
mechanism could also be relevant for other neurodegenera-
tive diseases in which neurofilament accumulation and loss 
of microtubules are prominent features.
Keywords Axon degeneration · Neurofilament · 
Microtubules · Stathmin · Stat3
Introduction
Destabilization of axon terminals and axon degenera-
tion are key pathological features in amyotrophic lateral 
sclerosis (ALS) and spinal muscular atrophy (SMA), the 
most common forms of motoneuron disease [6, 33, 62, 
68]. Despite progress in the identification of underlying 
gene defects [41, 58, 60], the cellular mechanisms that are 
responsible for loss of motor function, degeneration of neu-
romuscular endplates, destabilization of axons and finally 
death of motoneuron cell bodies are not fully understood 
[20]. SMA and ALS are considered both clinically and 
genetically as distinct disorders. However, they share com-
mon features. On the clinical side, dysfunction and degen-
eration of neuromuscular endplates appears as an early 
symptom in both disorders, and alterations of the axonal 
cytoskeleton are characteristic at early stages of both dis-
eases [16, 29, 35]. Accumulation of spheroids in proximal 
Abstract In neurons, microtubules form a dense array 
within axons, and the stability and function of this micro-
tubule network is modulated by neurofilaments. Accu-
mulation of neurofilaments has been observed in several 
forms of neurodegenerative diseases, but the mechanisms 
how elevated neurofilament levels destabilize axons are 
unknown so far. Here, we show that increased neurofila-
ment expression in motor nerves of pmn mutant mice, a 
model of motoneuron disease, causes disturbed microtu-
bule dynamics. The disease is caused by a point mutation 
in the tubulin-specific chaperone E (Tbce) gene, leading to 
an exchange of the most C-terminal amino acid tryptophan 
to glycine. As a consequence, the TBCE protein becomes 
instable which then results in destabilization of axonal 
microtubules and defects in axonal transport, in particu-
lar in motoneurons. Depletion of neurofilament increases 
the number and regrowth of microtubules in pmn mutant 
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axons is commonly observed in ALS, and these spheroids 
primarily contain neurofilaments [13, 23, 52]. In a mouse 
model of SMA, the density of intermediate filaments in 
proximal and distal axons is highly increased [9], similar 
as in tg(SOD1*G93A) mutant mice [75], a model for a 
common form of familial ALS. This increased density of 
neurofilaments coincides with lack of axonal sprouting and 
increased dynamics and instability of axonal microtubules 
[19, 22, 37, 38], indicating that the increased density of 
intermediate filaments and destabilization of microtubules 
are functionally connected.
Neurofilaments modulate microtubule stability and thus 
axon caliber and microtubule functions in axonal transport 
[49]. NFL is required for the assembly of neurofilaments, 
as NFM and NFH cannot form intermediate filaments in 
the absence of NFL [17, 18]. Abnormal accumulation of 
neurofilaments causes neuronal degeneration by disrupting 
axonal transport of cargos required for the maintenance of 
axon terminals [10]. Depletion of axonal neurofilaments in 
Nefl−/− and tg(Prph);Nefl−/− neurons leads to improved 
axonal transport of mitochondria and lysosomes [56]. It 
also increases life span in tg(SOD1*G85R) mutant mice 
[79] and attenuates the neurodegenerative disease pheno-
type in tau T44 transgenic mice [28]. However, the precise 
molecular mechanisms how neurofilament depletion stabi-
lizes microtubules, improves axonal transport and prevents 
axon degeneration have remained unclear.
Here we show that NFL depletion in pmn mutant mice 
[7, 46, 66] increases microtubule stability and delays axon 
degeneration. Disruption of the Nefl gene in pmn mutant 
mice increases microtubule numbers in motor axons, and 
ameliorates the disease phenotype. This effect appears to 
be caused by interaction of NFL with a protein complex 
including stathmin and signal transducer and activator of 
transcription-3 (Stat3). Interaction of Stat3 and stathmin is 
increased upon NFL depletion. Enhanced Stat3–stathmin 
interaction inhibits stathmin action in destabilizing micro-
tubules and increases levels of soluble tubulin heterodi-
mers making them available for the maintenance of axonal 
microtubules in motoneurons. This effect could explain 
why neurofilament depletion delays disease onset and pro-
longs survival in pmn mutant mice, and also how increased 
neurofilament levels lead to axonal destabilization in a 
wide variety of neurodegenerative disorders.
Materials and methods
Description of mouse lines used in this study
Heterozygous pmn mutant mice originally maintained on 
Naval Medical Research Institute (NMRI) [64] genetic 
background were crossed with heterozygous Nefl knockout 
mice on a C57BL/6 genetic background [83] to produce 
double heterozygous Nefl+/−; pmn+/− mice. These mice 
were then backcrossed with NMRI genetic background for 
at least four generations to obtain a uniform NMRI genetic 
background. Subsequently, the heterozygous Nefl+/−; 
pmn+/− were intercrossed to obtain the mice investigated 
in this work. NMRI genetic background was preferred 
over C57BL/6 to obtain bigger litter sizes under a situation 
when two autosomal recessive traits (pmn and Nefl) had to 
be crossed to obtain the desired genotypes. Nefl knockout 
and corresponding control wild-type mice on a C57BL/6 
genetic background were used for the immunoprecipitation 
experiments. All experimental procedures were approved 
by animal care and ethic committee of the University of 
Wuerzburg, the Veterinäramt of the City of Wuerzburg 
and the Regierung von Unterfranken, and were performed 
according to the guidelines of the European Union. All 
mice were maintained under a 12-h light/dark cycle with 
food and water ad libitum.
Antibodies
Antibodies against neurofilament-light chain Ab9035 
(Western blot), and NFL mouse monoclonal, Cat# MCA-
DA2 (immunostaining), tyrosinated α-tubulin (clone YL1/2; 
ab6160) and stathmin-1 (clone EP1573Y; ab52630) were 
obtained from Abcam. The specificity of these antibodies 
and in particular the stathmin antibody has been tested in 
previous studies [5, 66]. After stathmin-1 knockout [5] or 
lentiviral knockdown [66] the corresponding Stathmin-1 
band was completely abolished in Western blots. Neurofil-
ament-heavy chain antibody (AB5539) was obtained from 
Millipore, eIF2α (D7D3), p-STAT3Y705 (D3A7), and Stat3 
(124H6) (9139S) antibodies from Cell Signaling Technol-
ogy. γ-tubulin (clone GTU-88), tau (T-6402), acetylated-α-
tubulin (clone 6-11b-1; T7451) and α-tubulin (clone B-5-1-
2; T5168) antibodies were purchased from Sigma-Aldrich. 
The Stathmin 2 (SCG10) antibody was a kind gift from the 
lab of Dr. Gabriele Grenningloh, EPFL [15].
Survival of the mice
To compare survival of pmn mice lacking NFL, mice hete-
rozygous for Nefl+/−; pmn+/− were intercrossed, and sur-
vival of mutant mice of either sex with different genotypes 
was compared. Nefl+/+;pmn mice were used as a control 
for comparison with Nefl+/−;pmn and Nefl−/−;pmn to 
analyze survival with Kaplan–Meier curves. The median 
survival for the mice was compared using log rank test. 
Mice analyzed for survival were not used for the behavior 
tests.
95Acta Neuropathol (2016) 132:93–110 
1 3
Functional analysis of mice with rotarod and grip 
strength tests
Motor coordination and motor performance of the mutant 
mice were tested using a rotarod (Accelerating Rotarod, 
Ugo Basile) by recording the latency (time from begin-
ning of the trial until the mouse falls off) to fall off the 
rotating rod. Six mice from each genotype, Nefl+/+;pmn, 
Nefl+/−;pmn and Nefl−/−;pmn were tested at a presymp-
tomatic stage of postnatal day 21 and on three consecutive 
days when the mice showed signs of disease at the age of 
27, 28 and 29 days both on a constant speed (8 rpm, 10 min 
maximum per test) and an accelerating speed rotarod 
(linear acceleration from 4 to 40 rpm within 2 min). The 
latency to fall off the rotating rod (in seconds) was recorded 
for each mouse for three trials spaced by 10 min each. The 
average latency for all the 9 trials for each mouse for three 
consecutive days (27–29) was plotted and used for further 
analysis. Forelimb grip strength of mice was tested using an 
automatic grip strength meter (Chatillon, Columbus Instru-
ments) [47]. Mice were allowed to grasp a horizontal metal 
grid and pulled by their tail until the grip was released. The 
peak pull-force (in Newton) was recorded on the digital 
display. This test was performed for 6 trials per day at day 
21 when disease was not apparent and for three consecutive 
days (age of 27, 28 and 29 days) when the mice showed 
signs of disease. Average grip strength from day 21 and 
3 days at disease stages is plotted. The behavior tests were 
performed during the light cycle. All tests were performed 
on each mouse with a time gap of at least 1 h.
Primary motoneuron culture
Lumbar spinal cord was dissected from embryonic day 
13.5 mice as described [78]. Isolated spinal cord from each 
embryo was cleaned and trypsinized at 37 °C for 15 min 
in HBSS, containing trypsin at a final concentration of 
0.1 %. Trypsinization reaction was stopped by adding 
trypsin inhibitor (Sigma-Aldrich; T9128) to a final con-
centration of 0.1 % and digested tissues were gently tritu-
rated to obtain single cells. Panning plates were prepared 
by coating 24-well Nunclon™ surface dishes with antibody 
against p75NTR, clone MLR2 (a gift from R. Rush, Flinders 
University, Adelaide, Australia; [61] and also commer-
cially available through Biosensis (M-009-100) and Abcam 
(ab61425)), diluted to a final concentration of 5 ng/ml. 
Cells were transferred to panning dishes for 45 min where 
motoneurons expressing p75NTR receptor attach to the anti-
body coated surface of the dish. Enriched motoneurons 
were then plated on polyornithine and laminin-111 (catalog 
no. 23017–015, lot no. 1347084; Invitrogen) coated glass 
coverslips (Marienfeld) or dishes. These cells were cul-
tured at 37 °C temperature, 5 % CO2 in neurobasal medium 
(Invitrogen) containing 500 μM GlutaMAX (Invitrogen), 
2 % horse serum (Linaris), 2 % B-27 supplement (Invitro-
gen), and the neurotrophic factor BDNF (5 ng/ml). Culture 
medium was changed on day 1, 3 and 5 after plating. 2000 
cells were plated per 10 mm coverslip for measurements of 
axon length, 2000 cells per dish were plated for electron 
microscopic analyses and 5000 cells per 25 mm coverslip 
were plated for SIM.
Electron microscopy of primary motoneurons
Motoneurons were cultured on special Falcon dishes 
(BD Falcon™-Dish 35 × 10 mm non-TC Petri EZGrip 
500cas—BD Biosciences) for 7 days following the moto-
neuron culture protocol as described above. These moto-
neurons were fixed with 2.5 % glutaraldehyde and 0.8 % 
tannic acid in 0.1 M cacodylate buffer pH 7.5 (CB), for 
5 min at 37 °C followed by 90 min at room temperature. 
Neurons were then washed three times with CB and treated 
with 1 % OsO4 in CB for 1 h. Cells were subjected to dehy-
dration in 30, 50 % ethanol for 5 min each, followed by 
30 min 0.5 % uranyl acetate in 70 % ethanol, followed 
by 90, 96, 100 % ethanol for 5 min each, and were finally 
embedded in a thin sheet of Epon (Serva, Heidelberg, Ger-
many) resin. After polymerization, the resin sheets were 
stained with methylene blue for light microscopic iden-
tification of motoneurons. Resin pieces containing identi-
fied motoneurons were mounted on empty Epon blocks, 
ultrathin sections of ca. 80 nm were prepared, transferred 
to Formvar-coated nickel grids and contrasted with uranyl 
acetate and lead citrate [59]. Electron micrographs were 
obtained with a transmission electron microscope (LEO 
912 AB; Carl Zeiss). Intermediate filaments have a diam-
eter of 11.29 ± 0.46 nm. For measuring the IF density, 12 
parallel lines at a distance of 173 nm, perpendicular to the 
long axis of the axon were drawn on the micrograph and 
the number of intermediate filaments intersecting each line 
was counted [12]; for proximal axons (within 50 μm dis-
tance to the cell body), distal axons (less than 100 μm dis-
tance to the axon tip), and intermediate parts (in-between 
these two regions). Width of the axon was measured for 
each line and IF density was calculated by dividing the 
mean number of IF intersection by mean axon width.
Electron microscopy of phrenic nerves
Mice were killed by excessive CO2 exposure and transcar-
dially perfused with a mixture of 4 % paraformaldehyde 
(PFA) and 2 % glutaraldehyde in CB. Distal phrenic nerves 
were collected and postfixed in the same fixative over-
night at 4 °C. On the next day, nerves were washed with 
CB and treated with 2 % OsO4 in CB for 2 h, dehydrated 
in an ascending concentration of ethanol and embedded in 
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Epon. Transverse ultrathin sections of the nerve were trans-
ferred to Formvar-coated nickel grids and contrasted with 
uranyl acetate and lead citrate. Electron micrographs were 
obtained with a transmission electron microscope (LEO 
912 AB; Carl Zeiss). At least 3 mice from each genotype 
were used and microtubules were counted in transverse 
sections of axons from each mouse. Area of the axon was 
calculated using the ImageJ software (NIH).
Immunocytochemistry and light microscopic analysis
Motoneurons cultured for 3 or 7 days were fixed with 4 % 
PFA (freshly prepared) for 20 min at room temperature. 
PFA was washed out with PBS by 3 washes for 5 min each. 
Fixed neurons were treated with blocking solution (0.3 % 
Triton X-100, 0.1 % Tween-20, 10 % horse serum in PBS) 
for 30 min. Primary antibodies diluted in blocking solu-
tion were added onto the neurons and incubated overnight 
at 4 °C. On the following day, neurons were washed three 
times with washing solution (0.1 % Triton X-100, 0.1 % 
Tween-20 in PBS), 10 min each wash and incubated for 
1 h with the corresponding fluorescently labeled second-
ary antibodies at room temperature. Cells were washed 
with washing solution three times for 10 min each wash 
and mounted on object glass slides using aqua-polymount 
(Polysciences) and imaged under a confocal microscope 
(SP2; Leica) using a HC PL-APO 20×/0.70 objective. 
Axon length was measured using LAS AF software (Leica) 
by observers who were blind with respect to the genotype.
Structured illumination microscopy
For structured illumination microscopy (SIM) analysis, 
motoneurons were cultured for 3 days and fixed with the 
above described protocols. Neurons were labeled by indi-
rect immunofluorescence using secondary antibodies 
labeled with Alexa Fluor 488, Cy3 and Cy5. Specimens 
were imaged using a SIM Zeiss ELYRA S.1 microscope 
system with a 63×/1.40 oil immersion objective in x–y–z 
stacks. Raw images (16 bit) were processed to reconstruct 
high-resolution information using the provided commercial 
software package (Zeiss). Three-color images were aligned 
using a transformation matrix and were later processed 
with ImageJ. Shown are maximum-intensity projections of 
5 z-stacks.
Western blot analysis
Sciatic nerves from 34-day-old mice were isolated and 
lysed with a glass–glass homogenizer in RIPA buffer 
(50 mM Tris pH 7.4, 150 mM NaCl, 1 % Triton X-100, 
0.1 % SDS, 2 mM EDTA, protease inhibitor, 0.5 % sodium 
deoxycholate, 1 mM NaF, 10 mM sodium pyrophosphate, 
1 µM okadaic acid and 2 mM sodium orthovanadate). Con-
centration of protein was calculated using bicinchoninic 
acid assay (BCA assay) and lysate was boiled in Laemmli 
buffer for 10 min at 99 °C. Equal amount of protein from 
different samples were subjected to SDS-PAGE and trans-
ferred to nitrocellulose membranes. After incubation with 
the desired antibodies, membranes were developed using 
ECL or ECL advance (GE Healthcare). Obtained blots 
were scanned and band intensities were quantified by den-
sitometry analysis with ImageJ (NIH).
Immunoprecipitation
Sciatic nerves or NSC34 cells were lysed in IP buffer 
(50 mM Tris pH 7.4, 150 mM NaCl, 1 % Triton X-100, 
2 mM EDTA, Protease inhibitor, 1 mM NaF, 10 mM 
sodium pyrophosphate, 1 µM okadaic acid, 2 mM sodium 
orthovanadate) using a glass–glass homogenizer (only for 
sciatic nerves lysis) and at least 200 µg of protein lysate 
was incubated with 5 µl anti-stathmin (rabbit) antibody, 
overnight at 4 °C on a rotating wheel. The protein-antibody 
mix was incubated with pre-equilibrated Protein A-agarose 
beads (Roche) for 1 h at 4 °C on a rotating wheel. Protein 
coupled beads were pelleted by centrifugation at 500 rpm 
for 3 min at 4 °C and supernatant was stored at −20 °C. 
Beads were washed three times with IP buffer and pro-
teins were eluted by boiling the beads with 2X Laemmli 
buffer at 99 °C for 10 min. Eluted proteins were loaded on 
a SDS-PAGE and immunoblotting was done for stathmin, 
Stat3 and anti-NFL. The vector used for overexpression of 
NFL under a pRc/CMV promoter was supplied from Dr. JP 
Julien.
Microtubule‑regrowth assay
An established MT regrowth assay [1] with following mod-
ifications was used to study the MT regrowth in cultured 
motoneurons. 6000 cells were plated on polyornithine-
laminin coated 12 mm coverslips and incubated at 37 °C 
for 1 h. Cells were then provided with full medium (2 % 
horse serum, 1X B-27 and 5 ng BDNF) containing 10 µM 
nocodazole to depolymerize the microtubule network. After 
6 h of depolymerization, cells were washed 5 times with 
warm neurobasal (NB) medium and incubated at 37 °C for 
5 min with 500 µl of warm NB to investigate the regrowth 
of microtubules. These cells were then washed with MT 
stabilizing buffer PHEM (60 mM Pipes, 25 mM Hepes, 
10 mM EGTA, and 2 mM MgCl2) and MTs were extracted 
by adding PHEM with 0.5 % Triton X-100 and 10 µM 
paclitaxel for 3 min at 37 °C. Cells were rinsed with PHEM 
and fixed in 4 % PFA + PHEM (1:1). These motoneurons 
were then stained for α-tubulin to label polymerized MT 
and γ-tubulin to label the microtubule organizing center 
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(MTOC). Images were taken at a SP5 confocal microscope 
(Leica, Bensheim, Germany) with a 63X oil objective, 4X 
magnification and 1.35 NA Image J was used to quantify 
the regrowth of microtubules. After background subtraction 
of radius 50, similar threshold was set for all the images 
and Sholl analysis was performed to quantify the number 
of microtubule intersections at a step size of 1 µm. Total 
length of MT for each cell was determined by multiplying 
the number of intersections at each step by its distance from 
the MTOC, starting from the periphery to the center. Mean 
length was calculated by summing up the length of MTs 
obtained and divided by the total number of MTs meas-
ured: Σ ((nx − (nx + 1)) × ∆MTOCx)/N, where n is the 
number of intersections, x is the circle of interest, x + 1 is 
the next outer circle, ∆MTOCx is the distance from MTOC 
to the circle of interest, and N is the total number of MTs.
Reverse transcription, primer selection and qPCR
RNA from sciatic nerves of 1-month-old mice was iso-
lated using the trizol RNA isolation method. cDNA was 
prepared and qPCRs performed with a Lightcycler 1.5 
(Roche) with FastStart DNA master SYBR green1 rea-
gents, using kinetic PCR cycles. Efficiency-controlled 
relative expression levels were calculated. Intron-spanning 
primers were selected with Oligo 6.0 software (MedProbe) 
and PCR conditions were optimized. Reactions were per-
formed in glass capillaries in a volume of 20 µl. PCR prod-
ucts were analyzed by melting curve analysis. Primers and 
PCR targets: expression of housekeeping genes 5.8sRNA 
fw: 5′-GCGCTAGCTGCGAGAATTAATGTG-3′; rev-5′-
CAAGTGCGTTCGAAGTGTCGATGA-3′ and mHPRT1 
(NM_013556) fw: 5′-TTATGCCGAGGATTTGGAA-3′; 
rev-5′-ACAGAGGGCCACAATGTGAT-3′; 118 bp, intron-
spanning, were used for the relative quantification. mNefl 
(NM_010910) fw: 5′-CTAAGACCCTGGAGATCGAA-
GCC-3′; rev-5′-GCTCTTCGTGCTTCTCAGCTCATT-3′; 
149 bp, intron spanning. mStmn1 (NM_019641) 
fw: 5′-GCGCTTGCGAGAGAAGGACA-3′; rev-5′-
CTCGGGACAACTTAGTCAGCCTCA-3′; 99 bp, intron 
spanning.
Statistical analysis
Statistical analyses were performed using the GraphPad 
Prism 4.02 software (GraphPad, San Diego, CA, USA). 
A log rank test was used to test for the significance of 
differences in survival of mice as shown in the Kaplan–
Meier curves in Fig. 2a. Parametric tests were used for 
normally distributed data and non-parametric tests for 
data which were not normally distributed. All tests were 
two-tailed unless otherwise mentioned. All data are 
expressed as mean ± SEM. Final processing of all images 
was performed with ImageJ (Rasband, WS, ImageJ, US 
National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997–2015), [65] and Photoshop 
CS5 (Adobe). Brightness and contrast were enhanced for 
better visualization.
Results
Increased intermediate filament levels in pmn mutant 
motoneurons
Axonal accumulation of neurofilaments is a pathologi-
cal hallmark in many types of motoneuron disease. Pmn 
mutant mice suffer from a severe form of motoneuron dis-
ease which starts in third postnatal week and leads to death 
within 3–4 weeks [64]. In order to investigate the axonal 
pathology in pmn mice, we first analyzed the ultrastructure 
of phrenic nerves from 34-day-old pmn mice by electron 
microscopy. We observed a marked increase in number and 
density of intermediate filaments with typical diameter of 
approx. 10 nm in cross sections of phrenic nerve from pmn 
mutant mice (Fig. 1a). We then analyzed the ultrastruc-
ture of isolated embryonic motoneurons which were cul-
tured for 7 days in vitro. Analysis of proximal, intermedi-
ate and distal compartments of pmn motor axons showed 
an increase in number of intermediate filaments in all the 
compartments as compared to the wild-type axons (Fig. 1b, 
c). Next, we analyzed the levels of neurofilament proteins 
in peripheral nerves of pmn mutant mice. For this purpose, 
sciatic nerves were isolated from 34-day-old pmn mutant 
mice, representing an advanced stage of disease, and sub-
jected to Western blot analysis for NFL and NFH protein. 
Pmn mutant mice showed a significant increase in NFL 
and NFH protein levels in comparison to wild-type mice 
(Fig. 1d–f). Equal loading was controlled by determining 
eIF2α levels. The increase of NFL expression did not occur 
on the transcriptional level (Fig. 1g), indicating that altered 
translation or altered stability of neurofilaments accounts 
for this observation.
NFL depletion prolongs life span and improves motor 
performance in pmn mutant mice
In order to study the role of increased NFL in pmn disease 
phenotype, mutant mice were crossbred with Nefl knockout 
mice. Deletion of one Nefl allele reduced the levels of NFL 
in Nefl+/−;pmn littermates to control levels, as observed 
in wild-type mice (Fig. 1d, e). Also, the increased levels 
of NFH protein in pmn mice were normalized to wild-type 
levels in Nefl+/−;pmn mice (Fig. 1d, f).
To investigate the effect of increased neurofilament 
expression on the neurodegenerative process in pmn 
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mutant mice, we generated pmn mice completely lacking 
neurofilament light chain. Western blot analysis of sciatic 
nerve protein extracts from 34-day-old mice confirmed 
the absence of NFL (Fig. 1d) in Nefl−/−;pmn mice. Nefl 
deletion per se does not reduce survival of the mice, and 
Nefl knockout mice do not show an overt disease phe-
notype [83]. We followed the life span of pmn mice that 
lack NFL. Nefl−/−;pmn mice showed a significant exten-
sion of life span with an average increase of ~21 % in 
median survival as compared to Nefl+/+;pmn mice (log 
Fig. 1  Analysis of intermediate filament (IF) levels in axons of pmn 
mutant mouse motoneurons. a Electron micrograph of cross sec-
tions of distal phrenic nerve from 34-day-old mice showed increased 
intermediate filaments in pmn axons compared to wild-type axons, 
scale bar 500 nm (top). Bottom lane shows the higher magnification 
of the respective image in the top lane (scale bar 200 nm). Arrows 
point to IF. b Electron micrograph showing axonal compartments 
of motoneurons cultured for 7 days. Scale bar 500 nm. c Quantifi-
cation of number of IF in pmn axons showed an increase in proxi-
mal (P value = 0.0304), intermediate (P value = 0.0249) and distal 
(P value = 0.0336) compartments as compared to wild-type axons 
(Mann–Whitney one tailed test, n = 16 wild-type motoneurons and 
19 pmn motoneurons from 3 independent experiments). d Western 
blot analysis of sciatic nerve lysate from 34-day-old mice. e, f Pmn 
mutant mouse nerves show increased levels of e NFL (t = 3.210, 
P = 0.0326) and f NFH (t = 2.781, P = 0.0498) proteins as com-
pared to the wild type. Bars represent mean ± SEM, (n = 5 wild-
type and pmn and n = 3 Nefl+/−;pmn mice analyzed, *P < 0.05; 
one sample t test). g Expression levels of Nefl mRNA in sciatic nerve 
extracts of 28- to 30-day-old pmn is not changed compared to wild 
type. Quantification was performed by normalizing with HPRT1 as 
housekeeping gene. Bars represent mean ± SEM (n = 3)
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rank test; P = 0.0110, χ2 = 6.460; Fig. 2a). Median sur-
vival of Nefl−/−;pmn (n = 22) mice was 45 days and it 
was significantly higher than the median survival of 
37 days in Nefl+/+;pmn (n = 22 mice). Median survival 
of Nefl+/−;pmn (n = 27 mice) was 40 days. Of the 22 
mice analyzed at postnatal day 41, 18 Nefl−/−;pmn mice 
were still alive. At the same time point only 6 out of 22 
Nefl+/+;pmn were alive. Figure 2b shows the hind limb 
of pmn mice from the same litter with (left) and without 
(right) NFL at postnatal day 29. Notably, the pmn mouse 
with NFL exhibited completely atrophied hind limbs, at 
the same age when Nefl−/−;pmn showed still preserved 
hind limb motor function. The average weight of pmn, 
Nefl+/−;pmn and Nefl−/−;pmn mice did not differ sig-
nificantly at day 21 which represents a presymptomatic or 
early disease stage or at 27–29 days which marks a period 
of rapid disease progression (Fig. 2b, c).
In order to assess the motor performance and disease 
progression in Nefl−/−;pmn mice, we tested the grip 
strength of six mice per genotype and their performance on 
the rotarod on day 21 at disease onset and for three consec-
utive days (age of 27, 28 and 29 day) during a phase of fast 
disease progression (Fig. 2d, e). No significant difference 
was observed in the grip strength or rotarod performance 
between the three genotypes (Fig. 2d, e; supplementary 
Figure 3) at postnatal day 21. At day 27–29, we found that 
both Nefl−/−;pmn and Nefl+/−;pmn mice exhibited higher 
grip strength as compared to Nefl+/+;pmn mice (Fig. 2d), 
using a grip strength meter. There was a tendency towards 
higher latency to fall off the accelerated rotarod on day 21 
in Nefl−/−;pmn mutant mice but this difference was not 
statistically significant (n = 6–7 for each group, P > 0.05). 
At day 27–29, Nefl−/−;pmn and Nefl+/−;pmn mice 
showed an increase in the latency to fall off the rotating 
Fig. 2  Life-span and phenotype of pmn mutant mice lacking NFL. a 
Kaplan–Meier curve for comparison of life span of mutant mice (log 
rank test; n = 22 pmn and n = 22 Nefl−/−;pmn mice and n = 27 
Nefl+/−;pmn mice analyzed, P = 0.0110, χ2 = 6.460). b Represent-
ative images of 29-day-old mice from the same litter. Arrows show 
hind limbs of these mice. c Mice were weighed at postnatal day 21 
and 27–29 and showed no significant difference in average weight. 
d Peak forelimb grip strength in Newton (N) of mice measured at 
day 21 showed no significant difference, but at 27–29 Nefl+/−;pmn 
(P < 0.01; t = 4.007) and Nefl−/−;pmn (P < 0.01; t = 3.578) mice 
exhibited higher grip strength as compared to Nefl+/+;pmn mice. e 
On an accelerating speed rotarod, Nefl−/−;pmn (P < 0.05; t = 2.735) 
and Nefl+/−;pmn (P < 0.001; t = 5.206) mice showed an increase in 
the latency to fall as compared to Nefl+/+;pmn mice. c–e Bars repre-
sent mean ± SEM (one-way ANOVA and Bonferroni’s post hoc test, 
n = 6 mice per genotype, *P < 0.05, **P < 0.01, ***P < 0.001). Bars 
show average of the tests on postnatal day 21 and 27, 28 and 29 days
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rod, both on an accelerating (Fig. 2e) and a constant speed 
rotarod (Suppl. Figure 1) as compared to Nefl+/+;pmn 
mice. On the accelerating speed rotarod Nefl−/−;pmn 
could stay up to 50 s on the rod when the rotating speed 
was increased to 40 rpm, in contrast to Nefl+/+pmn mice 
which could not sustain the higher rotating speed at day 
27–29. Interestingly, Nefl+/−;pmn mice in which the NFL 
levels are comparable to wild-type mice performed bet-
ter in the rotarod test (Suppl. Figure 1) than Nefl−/−;pmn 
mice that completely lack NFL. Hence, deletion of Nefl 
from pmn mice does not influence disease onset, but pro-
longs survival of these mice, improves motor performance 
and partially ameliorates the disease phenotype.
NFL depletion increases microtubule number in motor 
nerves of pmn mice and rescues defective axon 
elongation in vitro
Pmn mutant mice exhibit reduced axonal microtubule 
density in the distal part of phrenic nerves [46, 63]. Simi-
larly, cultured motoneurons from pmn mutant mice show 
reduced axonal microtubule density in the proximal part 
of the axons [66]. On the other hand, Nefl−/− mice show 
increased microtubule numbers in axons within spinal 
cord and higher α-tubulin protein levels in the cerebral 
cortex [28]. In order to study the microtubule dynamics in 
Nefl−/−;pmn mice, we analyzed the ultrastructure of dis-
tal phrenic nerves in 34-day-old wild-type, pmn, Nefl−/− 
and Nefl−/−;pmn mice. Confirming previous analyses 
[46, 62] we observed a reduction in the number of micro-
tubules per axon in pmn mutant mice (Fig. 3a, b) as com-
pared to wild-type mice (wild-type 86.91 ± 9.793 and pmn 
41.52 ± 8.585) (P < 0.05; t = 3.640; one-way ANOVA). 
Deletion of Nefl prevented the loss of microtubules per axon 
in phrenic nerves of pmn mutant mice, and Nefl−/−;pmn 
(71.83 ± 4.858) axons showed microtubule numbers com-
parable to wild-type (Fig. 3a, b; P > 0.05; t = 1.306; one-
way ANOVA). However, the total number of microtubules 
per axon was not significantly higher in Nefl−/− mice 
(120.6 ± 11.47) compared to axons from control wild-type 
mice (86.91 ± 9.793; P > 0.05; t = 2.701), indicating that 
depletion of NFL resulted in maintenance or stabilization of 
microtubules but not in the generation of additional micro-
tubules. Pmn pathology did not alter axonal diameter and 
therefore the cross-sectional area of axons in phrenic nerve 
of pmn mice remained unaffected (Fig. 3d) at postnatal day 
34. In contrast, NFL appeared as a major modulator of axon 
caliber [24]. Confirming previous studies, we observed that 
NFL depletion led to a drastic reduction in the cross-sec-
tional area of the axons in Nefl−/− and Nefl−/−;pmn axons 
in phrenic nerves of 34-day-old postnatal mice as compared 
to wild-type controls (Fig. 3d). Consequently, the density of 
microtubules per axon increased drastically in Nefl−/− and 
Nefl−/−;pmn nerves as compared to wild-type and pmn 
controls (Fig. 3c) in postnatal nerves at stages when these 
mice show clinical symptoms. These data suggest that NFL 
depletion prevents destabilization of microtubules in pmn 
mice and leads to an increased density of microtubules in 
axons by reducing the axonal caliber in both wild-type and 
pmn mutant mice.
Arrangement, distribution and organization of micro-
tubules are essential for axonal outgrowth and elongation 
[14, 74]. Isolated motoneurons from pmn mutant mice 
show reduced axon outgrowth when cultured for 7 days 
in vitro [7], which could be rescued by CNTF applica-
tion [66]. In order to study the effect of increased micro-
tubule dynamics on axon elongation in pmn motoneurons 
lacking NFL, we measured and compared axon length of 
Nefl+/+;pmn and Nefl−/−;pmn mutant motoneurons cul-
tured for 7 days in vitro in presence of BDNF. CNTF was 
not present in these cultures. Pmn motoneurons showed 
significantly shorter axons when cultured with BDNF 
(Fig. 3e, f), whereas axons from Nefl−/− motoneurons 
grew comparable to those of wild-type motoneurons. Nefl 
deletion completely rescued the defect in axon elongation 
of pmn mutant motoneurons, and Nefl−/−;pmn motoneu-
rons grew significantly longer axons as compared to axons 
of pmn motoneurons, reaching axon lengths comparable to 
those of wild-type. Survival of Nefl−/− motoneurons after 
7 days in vitro did not differ from that of wild-type moto-
neurons (Fig. 3g).
Previous studies [66] showed that the axon diameter of 
cultured pmn motoneurons does not differ from wild-type 
controls, which is in line with the observations made in this 
study with axons from phrenic nerves of the same mutant 
mice at postnatal day 34 (Fig. 3d). In order to test how 
axons were altered in Nefl−/− motoneurons, longitudinally 
sectioned motor axons were analyzed under the electron 
microscope. Proximal, intermediate and distal compart-
ments of wild-type and Nefl−/− motor axons were used to 
measure the axonal diameter and the average diameter of 
wild-type and Nefl−/− axons is plotted. Axons of Nefl−/− 
motoneurons cultured for 7 days in vitro did not show 
changes in diameter as compared to wild type (Fig. 3h, i), 
indicating that the rescue effect observed in Nefl−/−;pmn 
mutant motoneurons is not a consequence of altered axon 
diameter.
Nefl deletion rescues microtubule regrowth defect 
in cultured pmn motoneurons
In order to study microtubule dynamics in Nefl−/− moto-
neurons, we investigated microtubule regrowth and polym-
erization in cultured motoneurons after complete disinte-
gration of microtubules. For this purpose, an established 
protocol for MT regrowth after nocodazole treatment was 
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Fig. 3  NFL depletion increases microtubule (MT) density and axon 
length in pmn mutant motoneurons. a Electron micrographs of distal 
phrenic nerve cross-sections from 34-day-old mice (top), scale bar 
500 nm. Bottom lane shows the higher magnification of the respec-
tive image in the top lane, scale bar 200 nm. Arrows point to MTs. 
b Number of MTs per axon in pmn (P < 0.05; t = 3.640) decreased, 
whereas Nefl−/−;pmn mice (P > 0.05; t = 2.701) showed MT 
number comparable to wild-type mice. c Density of MTs per axon 
in Nefl−/− (P < 0.001; t = 10.05) and Nefl−/−;pmn (P < 0.001; 
t = 9.649) mice increased as compared to wild-type axons. d Cross-
sectional area of Nefl−/− (P < 0.05; t = 3.416) and Nefl−/−;pmn 
(P < 0.01; t = 4.488) reduced as compared to wild-type and pmn 
axons (n = 3 pmn and Nefl−/− mice and n = 4 wild-type and 
Nefl−/−;pmn mice analyzed). e Representative images of motoneu-
rons cultured for 7 days in vitro. Scale bar 100 µm. f Pmn motoneu-
rons showed reduced axon length (P < 0.01; t = 6.845). Nefl−/−;pmn 
motoneurons grew significantly longer than pmn motoneurons 
(P < 0.01; t = 5.830) (n = 3 independent experiments). Numbers 
in the bars represents total number of motoneurons analyzed. Bars 
represent mean ± SEM (one-way ANOVA and Bonferroni’s post 
hoc test, *P < 0.05, **P < 0.01, ***P < 0.001). g Bar graph show-
ing no change in percentage survival of motoneurons after 7 days 
in vitro culture. h Electron micrographs showing longitudinal sec-
tion of axons of wild type and Nefl−/− motoneurons cultured for 
7 days in vitro. i Bar graph showing quantitative analysis of axonal 
diameter of cultured embryonic motoneurons from wild-type (n = 7) 
and Nefl−/− (n = 9) mice, showing no change in width after 7 days 
in vitro. 2–3 sections of each proximal, intermediate and distal axon 
were analyzed for each motoneuron and the average of all sections 
from the three compartments is shown in the figure
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used [1, 63, 66]. Isolated E13.5 motoneurons were plated 
in culture dishes for 1 h and the established microtubule 
network was completely depolymerized by applying 10 µM 
nocodazole for 6 h. Nocodazole was then washed off 
and microtubules were allowed to regrow. Sholl analysis 
(Fig. 4a, b) was performed to quantify MT polymerization, 
average MT length and total length of MT after regrowth. 
Pmn mutant motoneurons showed reduced MT regrowth 
when compared to wild-type motoneurons, as reported pre-
viously [66] (Fig. 4a, c). Nefl−/− motoneurons showed no 
change in MT repolymerization and the MT intersections 
appeared comparable to wild-type neurons (Fig. 4a, d). On 
the other hand, Nefl deletion significantly increased MT 
regrowth and repolymerization in pmn motoneurons, and 
Nefl−/−;pmn motoneurons showed significantly higher 
microtubule regrowth than pmn motoneurons (Fig. 4a, f) 
when cultured with BDNF.
Next, we measured the average length of microtubules. 
For this purpose, length of all the microtubules grow-
ing from the microtubule organizing center (MTOC) was 
measured and average length was calculated, as reported 
previously [66]. Pmn mutant motoneurons exhibited 
shorter average microtubule length compared to wild-type 
neurons (Fig. 4g). Nefl−/− motoneurons showed micro-
tubule length comparable to wild type. Average microtu-
bule length within Nefl−/−;pmn motoneurons was longer 
than the length of microtubules in pmn motoneurons and 
reached levels comparable to wild type and Nefl−/− con-
trols (Fig. 4g). We also measured the total length of 
microtubules and found that Nefl−/−;pmn motoneurons 
Fig. 4  NFL depletion enhances microtubule (MT) regrowth in pmn 
mutant motoneurons in vitro. a Representative images of motoneu-
rons showing depolymerized microtubules (MT) after nocodazole 
treatment and MT regrowth after 5 min of nocodazole washout. 
Microtubules (MT) are labeled using α-tubulin (green) and centro-
some by γ-tubulin (red). Bars 2 µm. b Representative image of Sholl 
analysis performed to count the number of MTs with 1 µm concen-
tric circles step. c–f Number of MT intersections (y axis) at increas-
ing distance (x axis) from microtubule organizing center (MTOC) 
was counted. Line graphs showing mean ± SEM (two-way ANOVA 
with Bonferroni’s post hoc test, n = 4 independent experiments, 
**P < 0.01, ***P < 0.001). g Average length of MTs from each 
MTOC is plotted. h Total length of MTs regrown from each MTOC is 
plotted. Bars represent mean ± SEM
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show an increase in total microtubule length originating 
from MTOC as compared pmn motoneurons, that showed 
reduced total microtubule growth (Fig. 4h).
NFL interacts with Stat3–stathmin complex and NFL 
depletion increases Stat3–stathmin interaction
CNTF-dependent restoration of axon length and main-
tenance of pmn motoneurons is mediated by local axonal 
activity of Stat3 [66]. Stat3 is activated upon CNTF appli-
cation and the activated Stat3 interacts with stathmin 
thereby inhibiting its microtubule destabilizing activity and 
preventing the axonal degeneration in pmn motoneurons. 
Stat3–stathmin interaction has been shown to be increased 
in motoneurons upon CNTF application [66]. We therefore 
studied the interaction of Stat3–stathmin in Nefl−/− mice. 
We performed immunoprecipitation with protein lysates 
of sciatic nerves from 34-day-old wild-type and Nefl−/− 
mice via stathmin pulldown and investigated the interaction 
partners of stathmin. This pulldown experiment revealed 
that NFL also interacts with stathmin (Fig. 5a). Sciatic 
nerve lysates from Nefl−/− mice showed an increase in 
Fig. 5  Nefl deletion increases Stat3–stathmin interaction. a Stath-
min was immunoprecipitated from sciatic nerve extracts of 34-day-
old mice. Western blot shows from left to right, input (Ip) and eluate 
(E) from wild-type and Nefl−/− mice nerve extracts after anti-IgG 
control and anti-stathmin pulldown. b Quantification of band inten-
sities in the eluate showed an increased interaction of Stat3 and 
stathmin in Nefl−/− mice (t = 17.08; P = 0.0034). Bars represent 
mean ± SEM (one sample t test, n = 3 independent experiments). 
c Nefl deletion increases Stat3–stathmin interaction in sciatic nerves 
from pmn mutant mice. d Western blot analyses show similar lev-
els of stathmin in the sciatic nerve extracts of 34-day-old wild-type, 
pmn and Nefl−/− mice. Histone levels were determined to ensure 
equal loading of proteins. e Quantification of Stat3 per stathmin lev-
els in the sciatic nerve extracts (input before immunoprecipitation) 
from 34-day-old wild-type and Nefl−/− mice (n = 3 independent 
experiments). f Stathmin was immunoprecipitated from NSC-34 cell 
extracts. Western blot shows from left to right input for IgG, mock, 
and NFL overexpressing NSC-34 cells. Right blot shows eluate after 
IgG control pulldown and stathmin pulldown from NSC-34 cells after 
transfection with mock (only lipofectamine) or, NFL overexpression 
vector, respectively. g Western blot analysis reveals increased lev-
els of phosphorylated Stat3 (at Y705) in the sciatic nerve extracts of 
34-day-old pmn and Nefl−/− in comparison to wild-type mice. Quan-
tification of pStat3 normalized by total Stat3 levels in h pmn mouse 
compared to wild type (t = 4.928; P = 0.0044; n = 6 independent 
experiments) and i in Nefl−/− mouse compared to the wild-type 
mouse (t = 2.865; P = 0.0242; n = 8 independent experiments). Bars 
represent mean ± SEM
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Stat3–stathmin interaction as compared to wild-type mice 
(Fig. 5a, b). Also in pmn mutant mice, NFL depletion led 
to an increase in Stat3–stathmin interaction in sciatic nerve 
extracts (Fig. 5c). In Western blots of sciatic nerve extracts, 
the levels of Stat3 (Fig. 5a) and stathmin (Fig. 5d) and 
also the ratio of Stat3/stathmin (Fig. 5e) were not altered, 
excluding the possibility that the enhanced Stat3–stath-
min interaction is due to altered expression of any of these 
two proteins. Similarly, Stathmin2 levels were unchanged 
in pmn mutant sciatic nerves (Suppl. Figure 2a) and the 
mRNA levels for Stmn1 were not changed in the adult 
pmn or Nefl−/− mouse sciatic nerves (Supplementary 
Figure 2b, c). Hence, depletion of NFL increases the inter-
action of Stat3–stathmin that antagonizes the MT-destabi-
lizing activity of stathmin [53].
In order to confirm the interaction of NFL and stathmin, 
we performed these immunoprecipitation experiments with 
NSC34 cells. For this purpose, cell lysates were subjected 
to stathmin pulldown and NFL and Stat3 interaction were 
studied by co-immunoprecipitation. Our data confirmed the 
interaction of NFL with stathmin in this cell culture system 
(Fig. 5f). Overexpression of NFL led to an increased inter-
action of NFL with stathmin and in parallel a decreased 
interaction with Stat3 (Fig. 5f).
Since the phosphorylation of Stat3 at Y705 plays an 
important role in its interaction with stathmin upon CNTF 
treatment [66], we studied the levels of phosphorylation 
of Stat3 in sciatic nerve extracts of 34-day-old Nefl−/− 
and pmn mice. The levels of phosphorylation showed an 
about fivefold increase in pmn nerve extracts (Fig. 5g, h). 
Nefl−/− nerve extracts also showed an increase in the 
phosphorylation at Y705, indicating that the increase in 
the stathmin/Stat3 interaction is mediated via activation of 
Stat3 (Fig. 5g , i).
Nefl deletion affects the distribution and interaction 
of Stat3 and stathmin with tubulin in motoneurons
Dimers of α- and β-tubulin are the basic components of 
microtubules. These heterodimers undergo a variety of 
post-translational modifications which assign specific 
functions to the tubulin subunits. Acetylation of α-tubulin 
occurs in polymerized microtubules, and the acetylated 
tubulin is enriched in stable microtubules with a low turno-
ver. On the other side, tyrosinated α-tubulin marks recently 
assembled more dynamic microtubules with a high turno-
ver [77]. In neurons, acetylated microtubules are found 
in more proximal parts of axons where microtubules are 
thought to be stable, and they appear to be excluded from 
axon terminals [66, 80]. In the highly dynamic axonal 
growth cones and dendrites, tyrosinated tubulins are found 
[66]. Pmn motoneurons exhibit more highly dynamic MTs 
in axons and show higher levels of tyrosinated tubulins in 
axons (Suppl. Figure 3) as compared to wild-type motoneu-
rons, whereas the levels of acetylated MTs are unchanged 
(Suppl. Figure 3 and [66]). We observed that NFL deple-
tion increased the intensity of staining against acetylated 
tubulin in axons of motoneurons (Fig. 6a, b). In the same 
axons, levels of tyrosinated microtubules did not change. In 
summary, these data indicate that NFL depletion enhances 
the stability of microtubules, as could be seen by the higher 
levels of acetylation.
This effect could be explained by reduced activity of 
stathmin. Stathmin appears redistributed in axons of pmn 
mutant motoneurons, with higher levels of this protein in 
association with NFL (Suppl. Figure 4). Stathmin has two 
functions on microtubules dynamics. On the one side, it 
binds to heterodimers of α- and β-tubulin and prevents the 
polymerization of new microtubules. On the other side, it 
interacts with polymerized microtubules and induces their 
disassembly in microtubule catastrophe reactions [8]. In 
order to study this possibility, we determined the subcel-
lular distribution of Stat3 and stathmin. In wild-type axons, 
Stat3 was observed to be co-localized with the tyrosinated 
tubulin whereas in the Nefl−/− axons Stat3 co-localized 
with stathmin (Fig. 7). These findings emphasize that the 
association of axonal Stat3 with stathmin modulates micro-
tubule dynamics in the neurons. In addition, they support 
the data obtained by stathmin immunoprecipitation and 
Western blot analysis showing that NFL modulates the 
interaction of Stat3 and stathmin. Thus, NFL depletion 
increases the interaction between Stat3 and stathmin and 
stabilizes microtubules by reducing the MT destabilizing 
activity of stathmin.
Discussion
In this study, we observed that NFL protein levels are at 
least twofold increased in pmn mutant motoneurons and that 
NFL depletion rescues defective axon growth in cultured 
motoneurons and prolongs survival of pmn mutant mice. 
This effect was found both in Nefl+/−;pmn motoneurons 
in which elevated NF expression was brought back to wild-
type control levels and in Nefl−/−;pmn motoneurons in 
which axonal neurofilament was completely lost. In cultured 
pmn mutant motoneurons, NFL depletion also resulted in 
increased axon elongation and increased levels of acetylated 
tubulin, a marker for stable microtubules. Thus, NFL deple-
tion modulates microtubule dynamics in a similar manner as 
observed after Stat3 activation. This effect was apparently 
due to increased phosphorylation of Stat3 and enhanced 
interaction of Stat3 with stathmin when NFL levels were 
reduced, resulting in enhanced stability of microtubules.
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Accumulation of neurofilaments has been observed in a 
variety of neurodegenerative diseases and in correspond-
ing mouse models [36, 42, 44]. Thus neurofilament pathol-
ogy represents a point where pathomechanisms of distinct 
neurodegenerative disorders converge [40]. However, the 
reasons why NFL is upregulated in degenerating neurons 
and the precise mechanism how NFL accumulation partici-
pates in these neurodegenerative mechanisms are not fully 
understood so far. Several lines of evidence indicate that 
defective axonal transport leads to enhanced phosphoryla-
tion and accumulation of neurofilaments in axons [55]. The 
upregulation could also be a consequence of altered post-
transcriptional control [73], or a consequence of defec-
tive intermediate filament degradation. The possibility of 
increased protein synthesis has been ruled out in degen-
erating neurons of ALS and Alzheimer disease patients in 
which NEFL mRNA levels are downregulated [3, 48, 71, 
72, 81], whereas the transcript levels for NEFM or NEFH 
usually remain unchanged [81]. This indicates that both 
altered axonal transport, posttranscriptional mechanisms 
including deregulated translation or posttranslational mech-
anisms such as reduced degradation of NFL [60] could be 
responsible for the phenotype. Gigaxonin plays an essen-
tial role in the degradation of IFs [54] and the accumulated 
pool of IF in giant axonal neuropathy is lost upon Gigax-
onin restoration in patient iPSC derived motoneurons [31], 
indicating that defective degradation could play a central 
role in this and other forms of neurodegenerative disorders.
Mouse models of motoneuron disease and other neu-
rodegenerative disorders have provided support for the 
hypothesis that accumulation of NFL could be an early 
event in neurodegeneration. Overexpression of NFL, NFM 
or NFH transgenes causes NF aggregation and motoneu-
ron dysfunction resembling motoneuron disease in mouse 
Fig. 6  Levels of tyrosinated and acetylated tubulin in NFL-depleted 
motoneurons a Representative images of motoneurons show-
ing increased acetylated microtubules in Nefl−/− motoneurons 
after 3 days in vitro culture. Neurons were stained with antibodies 
against tyrosinated α-tubulin (green), stathmin (blue) and acetylated 
α-tubulin (red). Scale bar 20 µm (first and third lane). White square 
boxes indicate the regions enlarged in the second and fourth lane, 
scale bar 2 µm. b Quantification of fluorescence intensities showed 
increased acetylated microtubules in Nefl−/− (t = 3.011) as com-
pared to wild-type motoneurons, whereas tyrosinated microtubules 
remained unchanged. Intensity of stathmin is used as control. Bars 
represent mean ± SEM (one-way ANOVA, n = 10 motoneurons from 
three independent experiments, *P < 0.05, ***P < 0.001)
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models [11, 21, 34, 82]. In mutant SOD1 mice, Nefl dele-
tion delayed the onset of disease and slowed the disease 
progression [79], and in tau transgenic mouse it reduces the 
abnormal tau accumulation and motoneurons degeneration 
[28]. In pmn mutant mice, deletion of only one Nefl allele 
normalized NFL and NFH protein levels in sciatic nerves. 
Under these conditions, the motor function in pmn mutant 
mice was improved, thus providing evidence that the ele-
vation of endogenous neurofilament levels contributes to 
axon destabilization and loss of motor function. Despite the 
drastic reduction of IFs and the resultant reduction in axon 
diameter in peripheral nerves, Nefl−/−;pmn mutant mice 
survived longer than Nefl+/−;pmn or pmn mutant mice. 
Thus, loss of IFs delays axon destabilization in pmn mutant 
mice.
Microtubules in pmn mutant mice are unstable, because 
the underlying gene defect leads to a massive reduction of 
αβ-tubulin heterodimers, the basic components of microtu-
bules [46]. In cultured motoneurons, this leads to defective 
axon elongation [63, 66], and levels of tyrosinated micro-
tubules are increased in the axons of these motoneurons. 
Intermediate filaments are anatomically and functionally 
linked with microtubules. Neurofilament interacts with 
tubulin [50] and stimulates microtubule polymerization 
in mature neurons [4]. Any disturbance of NF protein 
levels does not only affect assembly of NF fibers, it also 
influences microtubules [30]. NFM and NFH make cross 
bridges between adjacent NFs and microtubules [51]. 
Thus, also removal of NFM and NFH sidearms delays the 
disease in SOD1 mutant mice [43] in a similar manner as 
deletion of the Nefl gene in this mouse model [79]. Disease 
onset is also delayed in the same mouse model after treat-
ment with microtubule stabilizing agents [19]. However, it 
has not been shown so far whether stabilization of micro-
tubules contributes to the beneficial effects of NFL deple-
tion or removal of NFM and NFH sidearms in SOD1 mice. 
The observation made in our study that levels of acetylated 
tubulin increase in axons of NFL-deficient motoneurons 
Fig. 7  Distribution of Stat3 and stathmin in axons of wild-type and 
Nefl−/− motoneurons as revealed by high-resolution SIM. Moto-
neurons were cultured for 3 days in vitro. Representative images of 
wild-type and Nefl−/− motoneurons, stained with antibodies against 
tyrosinated α-tubulin (green), Stat3 (red), and stathmin (blue). The 
antibody against tyrosinated α-tubulin stains both soluble αβ-tubulin 
heterodimers and polymerized highly dynamic microtubules. Note 
that the colocalization of stathmin with Stat3 increases in Nefl−/− 
motoneurons (right panel). Scale bar 20 µm (first and third lane). 
White square boxes indicate the regions enlarged in the second and 
fourth lane, scale bar 2 µm
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points to this possibility, and indicates that the beneficial 
effects of normalizing IF levels or those of massive reduc-
tion of functional IFs could be due to the stabilization of 
microtubules.
The levels of tyrosinated tubulin are increased in all 
compartments of the pmn mutant axons (Suppl. Figure 3) 
as observed in cultured motoneurons using light micros-
copy. The ultrastructural analyses of these pmn mutant 
axons (Fig. 1c) indicate that the increase of IF also occurs 
in all compartments with a gradient from proximal to dis-
tal, which however is similar in motoneurons from wild-
type and pmn mutant mice. Thus the structural alterations 
in NFL upregulation do not go in parallel with dying back 
mechanisms in the cultured motoneurons, but they are 
thought to be of relevance for axonal transport processes 
in vivo which could contribute the degeneration of distal 
parts of the axons.
Stathmin plays a central role in the regulation of micro-
tubule stability [8]. It acts in two distinct ways on microtu-
bule dynamics. First, it destabilizes existing microtubules 
by inducing microtubule catastrophes in a dose-dependent 
fashion in vitro [2, 26, 45]. Second, it binds αβ-tubulin het-
erodimers and sequesters them in a way that microtubule 
polymerization is inhibited [32]. In vitro, a change in the 
pH of the buffer can lead to a shift in the role of stathmin 
from sequestration of tubulin affecting microtubule elon-
gation to increase in microtubule catastrophes [27]. The 
N-terminal of stathmin is required for the catastrophic role, 
whereas the C-terminal is essential for the inhibition of 
MT-polymerization rate in vitro [25, 39]. These effects on 
regulating microtubule dynamics apparently are involved in 
plasticity processes when neurons change their shape and 
new neuronal connections are made, for example during 
learning and memory processes. Mice which lack stath-
min-1 show severe defects in fear memory formation in the 
amygdala [69, 76] and this process correlates with high lev-
els of stahmin-1 expression found in this brain region. Not 
much is known about how stathmin function is regulated, 
but its spatial distribution within cells seems to play a role 
[67]. Several members of the stathmin family are associated 
with membranous structures by palmitoylation that orients 
these proteins to specific subcellular compartment and 
thus restricts their subcellular distribution [8]. On the other 
hand, stathmin-1 lacks a palmitoylation signal, but this pro-
tein is not evenly distributed in the cytoplasm. In our study, 
we find stathmin-1 within axons, mostly colocalized with 
microtubules. High-resolution light microscopy with struc-
tured illumination microscopy (SIM) allowing resolution 
of structures down to nearly 100 nm reveals close proxim-
ity of stathmin with tyrosinated microtubules in the axons 
of wild-type motoneurons. This proximity seems to be 
increased in Nefl−/− motoneurons, and stathmin colocali-
zation with Stat3 and microtubules also increases, as shown 
in Fig. 7, right panel. This increased interaction of stathmin 
with Stat3 is confirmed by biochemical immunoprecipita-
tion assays. Neurofilament appears as part of this complex 
in pulldown assays, indicating that IFs play a role in the 
formation of complexes between Stat3 and stathmin. This 
could explain why IF depletion modulates microtubule 
stability.
In wild-type motoneurons, NFL depletion had a much 
more pronounced effect on stability of existing micro-
tubules that are acetylated at relatively high levels when 
compared to microtubule regrowth after nocodazole treat-
ment. In pmn mutant motoneurons in which availability 
of αβ-tubulin heterodimers is reduced, NFL depletion also 
restored defective microtubule regrowth after nocodazole 
treatment. This differential effect of NFL depletion could 
be explained by the reduced availability of αβ-tubulin het-
erodimers in pmn mutant motoneurons, which increases 
upon release of αβ-tubulin heterodimers when stathmin is 
inactivated by enhanced interaction with Stat3 [66]. Thus, 
the increased interaction of Stat3 and stathmin in NFL-
depleted motoneurons enhances the capacity for microtu-
bule regrowth and microtubule plasticity in motoneurons 
from pmn mutant mice. This also indicates that enhanced 
NFL levels in neurodegenerative diseases reduce the capac-
ity for microtubule regrowth and microtubule plasticity. 
Our data provide evidence that the destabilizing activity 
of stathmin is enhanced when NFs are increased in pmn 
pathology and probably in other neurodegenerative disor-
ders, and this could make a major contribution to axonal 
degeneration.
When this idea is followed up towards therapeutic impli-
cations, this would mean that catastrophe-inducing endog-
enous MT deregulators such as stathmin proteins should 
be functionally blocked in order to stabilize microtubules 
and to enhance stability of axons in conditions involving IF 
accumulation or microtubule destabilization. In neurons, 
altered MT-based transport and aggregation of proteins is 
generally associated with neurodegenerative disorders [57, 
70]. Despite the fact that axons exhibit smaller diameter, 
the improvement in MT network in Nefl−/−;pmn moto-
neurons apparently stabilizes the axon and possibly also 
improves the transport of cargoes, leading to prolonged 
survival and delay in the decline of motor function.
In summary, our findings suggest that NF accumula-
tion contributes to axonal destabilization in the pmn mouse 
model of motoneuron disease and possibly also other forms 
of neurodegenerative disorders. NFL depletion stabilizes 
the MT structure and leads to enhanced axon growth in 
pmn mutant motoneurons via increased activation of Stat3 
by phosphorylation at Y705 and thereby increased Stat3–
stathmin interaction. Thus, targeting the NFL accumulation 
in neurodegenerative diseases could be a target for therapy 
in neurodegenerative disorders.
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